Steward Partners Investment Advisory’s Cantel Medical Corporation CMD Stock Holding History

Steward Partners Investment Advisory’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-171	Closed	-$13.7K	–	7579
2021 Q1	$13.7K	Hold	171	–	–	﹤0.01%	2649
2020 Q4	$13K	Hold	171	–	–	﹤0.01%	2228
2020 Q3	$8K	Hold	171	–	–	﹤0.01%	2239
2020 Q2	$8K	Hold	171	–	–	﹤0.01%	2143
2020 Q1	$6K	Hold	171	–	–	﹤0.01%	2052
2019 Q4	$12K	Hold	171	–	–	﹤0.01%	1965
2019 Q3	$12K	Hold	171	–	–	﹤0.01%	1930
2019 Q2	$13K	Buy	+171	New	+$12K	﹤0.01%	1888
2018 Q4	–	Sell	-18	Closed	-$2K	–	2427
2018 Q3	$2K	Sell	18 -4	-18%	-$381	﹤0.01%	2441
2018 Q2	$2K	Buy	+22	New	+$2.46K	﹤0.01%	2288

Steward Partners Investment Advisory's CMD Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 171 shares — an estimated $13.7K sold.

Steward Partners Investment Advisory first reported a position in CMD in Q2 2018 and held it in 10 quarters. The position peaked at $13.7K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Steward Partners Investment Advisory reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Steward Partners Investment Advisory sold 171 Cantel Medical Corporation shares in Q2 2021, an estimated $13.7K.
Steward Partners Investment Advisory first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 10 quarters.
Steward Partners Investment Advisory's Cantel Medical Corporation position peaked at $13.7K in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.